MONEY

Taglich Brothers Publishes Updated Coverage Report on Cosmos Health; Maintains Price Target of $4, Nearly 300% Above Current Share Price

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 18, 2024 - 00:00
Taglich Brothers Publishes Updated Coverage Report on Cosmos Health; Maintains Price Target of $4, Nearly 300% Above Current Share Price
Read More

Tags:

Previous Article

Clasquin: H1 2024

Next Article

Announcing Workday Illuminate™: The Next Generation of Workday AI

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

FTSE 100 inches higher on commodity strength; US data in focus

FTSE 100 inches higher on commodity strength; US data i...

Tomas Kauer - Mode... Sep 11, 2024

KEYTRUDA ® (pembrolizumab) Plus LENVIMA ® (lenvatinib) in Combination With Transarterial Chemoembolization Significantly Improved Progression-Free Survival Compared to TACE Alone in Patients With Unre

KEYTRUDA ® (pembrolizumab) Plus LENVIMA ® (lenvatinib) ...

Tomas Kauer - Mode... Sep 15, 2024

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.88%

Denmark stocks higher at close of trade; OMX Copenhagen...

Tomas Kauer - Mode... Sep 14, 2024